<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">Africa boasts a demographic advantage of having a relatively young population, with a median age of 20â€‰years [
 <xref ref-type="bibr" rid="CR51">51</xref>]. With current evidence showing that severe COVID-19 mostly affects people of advanced age associated with noncommunicable diseases [
 <xref ref-type="bibr" rid="CR52">52</xref>], the odds of survival appear to favour Africans. Furthermore, the expression pattern of human angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 to gain entry into cells, appears to be low in Africans compared to Asians, further favouring the possibility of positive outcomes [
 <xref ref-type="bibr" rid="CR53">53</xref>, 
 <xref ref-type="bibr" rid="CR54">54</xref>].
</p>
